Outlook Therapeutics Non-GAAP EPS of -$0.09 misses by $0.02, revenue of $0.01M misses by
· seekingalpha.com
Outlook Therapeutics press release (OTLK): Q3 Non-GAAP EPS of -$0.09 misses by $0.02. Revenue of $9K (vs. $1.51M Y/Y) misses by $0.96M.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...